Medicinal Chemistry | Pharmacology Synthetically Accessible de novo Design using Reaction Vectors: Application to PARP1 Inhibitors. January 23, 2024
Artificial Intelligence | Oncology | Pathology Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. June 8, 2022